Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Orthopedic

PUBLISHER: Grand View Research | PRODUCT CODE: 1790294

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1790294

Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single, Three & Five Injections), By End Use (Hospitals & Orthopedic Clinics/ASCs), By Region (North America, Europe, APAC, LATAM & MEA), And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Viscosupplementation Market Summary

The global viscosupplementation market size was estimated at USD 5.30 billion in 2024 and is projected to reach USD 9.39 billion by 2033, growing at a CAGR of 6.21% from 2025 to 2033. Viscosupplementation aims to alleviate joint pain and enhance the functional state of the knee.

The growing incidence of osteoarthritis plays a significant role in driving the demand for viscosupplementation. Osteoarthritis, a chronic degenerative joint disease, is the primary cause of enduring disability. It typically emerges after the age of 30 and can progress to a disabling condition within a decade of diagnosis. In March 2025, an article published in Scientific Reports analyzed osteoarthritis data from the Global Burden of Disease Study 2021. The study reported a sharp rise in global OA incidence from 20.9 million cases in 1990 to 46.6 million in 2021, with a notable increase in years lived with disability. It also highlighted growing health inequalities, with a higher burden seen among women, in high SDI countries, and regions like Asia.

The rising incidence of joint disorders is a key driver of the viscosupplementation market. Degenerative conditions are becoming more common due to aging populations and sedentary lifestyles. This is leading to greater demand for non-surgical treatment approaches that provide symptom relief. Viscosupplementation addresses this by improving joint lubrication and mobility. Healthcare systems are recognizing the cost-effectiveness of delaying surgical intervention. In November 2024, an article in Osteoarthritis and Cartilage highlighted that osteoarthritis affected 7.6% of the global population in 2020, with prevalence increasing by 132.2% over the past 30 years. Moreover, it is noted that early-onset OA cases, occurring before age 55, accounted for over half of new diagnoses and 26.1% of total YLDs.

Preference for minimally invasive treatment options is contributing to market expansion. Patients and providers are increasingly opting for procedures that offer reduced recovery time and fewer complications. Viscosupplementation aligns with these needs, supporting its adoption in routine clinical practice. Ongoing developments in formulation are also influencing uptake. Single and multiple-injection regimens are now available to accommodate different patient profiles. In April 2024, a study published in Cureus analyzed arthritis trends among U.S. adults using BRFSS data from 2019 to 2022. The findings underscored rising prevalence and disparities by demographics and health status. These insights support growing adoption of minimally invasive surgeries (MIS) for arthritis, aimed at reducing pain, complications, and recovery time.

Growing awareness among healthcare providers and structured reimbursement policies are further supporting market growth. Continued clinical validation has led to broader acceptance of viscosupplementation in standard care protocols. This is encouraging its use at earlier stages of joint degeneration. Market players are responding with expanded product offerings to meet rising clinical demand. Regional regulatory support has facilitated product availability across key markets. In January 2024, Seikagaku Corporation announced collaborations with Anika Therapeutics and two other manufacturers to enhance multi-injection viscosupplementation products using novel cross-linked hyaluronic acid technologies.

Global Viscosupplementation Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global viscosupplementation market report based on product, end use, and region:

  • Product Outlook (Revenue in USD Billion, 2021 - 2033)
  • Single Injection
  • Three Injection
  • Five Injection
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospitals
  • Orthopedic Clinics/ASCs
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-1-68038-982-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Viscosupplementation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of osteoarthritis among aging populations
      • 3.2.1.2. Rising demand for non-surgical pain management options in orthopedics
      • 3.2.1.3. Advancements in hyaluronic acid formulations improving product efficacy
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment limiting access in low- and middle-income countries
      • 3.2.2.2. Limited long-term effectiveness leading to physician skepticism and guideline restrictions
  • 3.3. Viscosupplementation: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis

Chapter 4. Viscosupplementation Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global viscosupplementation market, by product, 2021 to 2033
  • 4.5. Single injection
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Three injection
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Five injection
    • 4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Viscosupplementation Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Segment Dashboard
  • 5.3. Global viscosupplementation market, by End Use, 2021 to 2033
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Orthopedic Clinic/ASCs
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Viscosupplementation Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Viscosupplementation Market Share by Region, 2024 & 2033:
  • 6.5. North America
    • 6.5.1. North America viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. U.S. viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Canada viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Mexico viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. UK viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Germany viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. France viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Italy viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Spain viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Scenario
      • 6.6.7.4. Norway viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Regulatory Framework
      • 6.6.8.3. Competitive Scenario
      • 6.6.8.4. Sweden viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Regulatory Framework
      • 6.6.9.3. Competitive Scenario
      • 6.6.9.4. Denmark viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Regulatory Framework
      • 6.7.1.3. Competitive Scenario
      • 6.7.1.4. Japan viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. China viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. India viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Framework
      • 6.7.4.3. Competitive Scenario
      • 6.7.4.4. Australia viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Regulatory Framework
      • 6.7.5.3. Competitive Scenario
      • 6.7.5.4. South Korea viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Regulatory Framework
      • 6.7.6.3. Competitive Scenario
      • 6.7.6.4. Thailand viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Regulatory Framework
      • 6.8.1.3. Competitive Scenario
      • 6.8.1.4. Brazil viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. Argentina viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key Country Dynamics
      • 6.9.1.2. Regulatory Framework
      • 6.9.1.3. Competitive Scenario
      • 6.9.1.4. South Africa viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Regulatory Framework
      • 6.9.2.3. Competitive Scenario
      • 6.9.2.4. Saudi Arabia viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Regulatory Framework
      • 6.9.3.3. Competitive Scenario
      • 6.9.3.4. UAE viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Regulatory Framework
      • 6.9.4.3. Competitive Scenario
      • 6.9.4.4. Kuwait viscosupplementation market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
  • 7.4. Heatmap Analysis, 2024
  • 7.5. Company Profile
    • 7.5.1. DePuy Synthes
      • 7.5.1.1. Company Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. Fidia Farmaceutici S.p.A
      • 7.5.2.1. Company Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Sanofi
      • 7.5.3.1. Company Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Anika Therapeutics, Inc.
      • 7.5.4.1. Company Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. SEIKAGAKU CORPORATION
      • 7.5.5.1. Company Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Zimmer Biomet
      • 7.5.6.1. Company Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Smith & Nephew PLC
      • 7.5.7.1. Company Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Ferring Pharmaceutical B.V.
      • 7.5.8.1. Company Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Lifecore Biomedical, LLC (Landec)
      • 7.5.9.1. Company Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. LG Life Sciences Ltd.
      • 7.5.10.1. Company Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic initiatives
    • 7.5.11. F. Hoffmann-La Roche Ltd.
      • 7.5.11.1. Company Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic initiatives
Show more
Product Code: GVR-1-68038-982-1

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 4 North America Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 6 U.S. Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 7 Canada Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 8 Canada Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 9 Mexico Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 10 Mexico Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 11 Europe Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 12 Europe Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 13 UK Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 14 UK Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 15 Germany Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 16 Germany Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 17 France Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 18 France Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 19 Italy Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 20 Italy Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 21 Spain Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 22 Spain Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 23 Sweden Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 24 Sweden Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 25 Denmark Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 26 Denmark Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 27 Norway Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 28 Norway Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 31 Japan Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 32 Japan Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 33 China Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 34 China Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 35 India Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 36 India Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 37 Australia Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 38 Australia Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 39 South Korea Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 40 South Korea Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 41 Thailand Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 42 Thailand Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 43 Latin America Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 44 Latin America Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 45 Brazil Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 46 Brazil Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 47 Argentina Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 48 Argentina Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 49 MEA Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 50 MEA Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 51 South Africa Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 52 South Africa Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 53 Saudi Arabia Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 54 Saudi Arabia Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 55 UAE Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 56 UAE Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 57 Kuwait Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 58 Kuwait Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Viscosupplementation market: outlook
  • Fig. 8 Viscosupplementation competitive insights
  • Fig. 9 Ancillary market outlook
  • Fig. 10 Viscosupplementation market driver impact
  • Fig. 11 Viscosupplementation market restraint impact
  • Fig. 12 Porter's Analysis
  • Fig. 13 PESTLE Analysis
  • Fig. 14 Viscosupplementation market: Product movement analysis
  • Fig. 15 Viscosupplementation market: Product outlook and key takeaways
  • Fig. 16 Single injection market estimates and forecast, 2021 - 2033
  • Fig. 17 Five injection market estimates and forecast, 2021 - 2033
  • Fig. 18 Toe intramedullary implants market estimates and forecast, 2021 - 2033
  • Fig. 19 Three injection market estimates and forecast, 2021 - 2033
  • Fig. 20 Scaphoid bone implants market estimates and forecast, 2021 - 2033
  • Fig. 21 Viscosupplementation market: End Use movement analysis
  • Fig. 22 Viscosupplementation market: End Use outlook and key takeaways
  • Fig. 23 Orthopedic Clinic/ASCs market estimates and forecasts, 2021 - 2033
  • Fig. 24 Hospitals market estimates and forecasts,2021 - 2033
  • Fig. 25 Global viscosupplementation market: Regional movement analysis
  • Fig. 26 Global viscosupplementation market: Regional outlook and key takeaways
  • Fig. 27 North America viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Key country dynamics
  • Fig. 29 U.S. viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 Canada viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Mexico viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Europe viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 UK viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Germany viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Spain viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 France viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Norway viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Denmark viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Sweden viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Asia Pacific viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Japan viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 China viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 India viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Australia viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 South Korea viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Thailand viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Latin America viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Brazil viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Argentina viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 MEA viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 South Africa viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Saudi Arabia viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 UAE viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Kuwait viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key company categorization
  • Fig. 79 Heat map analysis, 2024
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!